Ruochuan Zang

1.4k total citations
38 papers, 870 citations indexed

About

Ruochuan Zang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ruochuan Zang has authored 38 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Ruochuan Zang's work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Ruochuan Zang is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Diagnosis and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Ruochuan Zang collaborates with scholars based in China, United States and United Kingdom. Ruochuan Zang's co-authors include Nan Sun, Jie He, Yuanyuan Lei, Jianbing Huang, Zhiliang Lu, Shuangshuang Mao, Chengming Liu, Sufei Zheng, Yun Che and Shugeng Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Construction and Building Materials and European Journal of Cancer.

In The Last Decade

Ruochuan Zang

36 papers receiving 863 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruochuan Zang China 17 413 410 329 277 142 38 870
Weifeng Hong China 15 304 0.7× 500 1.2× 263 0.8× 364 1.3× 238 1.7× 52 925
Xin-Ran Tang China 19 306 0.7× 605 1.5× 259 0.8× 424 1.5× 122 0.9× 34 1.0k
Wen Liu China 15 525 1.3× 407 1.0× 210 0.6× 182 0.7× 94 0.7× 59 885
Francesca Simionato Italy 17 455 1.1× 290 0.7× 199 0.6× 199 0.7× 111 0.8× 31 794
Satoshi Muto Japan 18 406 1.0× 246 0.6× 311 0.9× 223 0.8× 229 1.6× 72 898
Federica Biello Italy 20 634 1.5× 267 0.7× 418 1.3× 292 1.1× 154 1.1× 56 994
Pietro De Placido Italy 13 488 1.2× 245 0.6× 396 1.2× 225 0.8× 50 0.4× 53 816
Naoyuki Okabe Japan 15 392 0.9× 212 0.5× 255 0.8× 197 0.7× 173 1.2× 56 706
Jie‐Ying Liang China 12 258 0.6× 536 1.3× 483 1.5× 518 1.9× 115 0.8× 24 909

Countries citing papers authored by Ruochuan Zang

Since Specialization
Citations

This map shows the geographic impact of Ruochuan Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruochuan Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruochuan Zang more than expected).

Fields of papers citing papers by Ruochuan Zang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruochuan Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruochuan Zang. The network helps show where Ruochuan Zang may publish in the future.

Co-authorship network of co-authors of Ruochuan Zang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruochuan Zang. A scholar is included among the top collaborators of Ruochuan Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruochuan Zang. Ruochuan Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zang, Ruochuan, et al.. (2024). Probabilistic fatigue modelling of concrete materials incorporating recycled tyre rubber under flexural loadings. Construction and Building Materials. 435. 136862–136862. 3 indexed citations
2.
Zang, Ruochuan, Bo Xu, Lin Zhao, et al.. (2024). Triaxial mechanical behaviour and constitutive response of rubberised concrete materials. Construction and Building Materials. 450. 138635–138635.
3.
Zhou, Bolun, Ruochuan Zang, Peng Song, et al.. (2023). Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study. Journal of Translational Medicine. 21(1). 10–10. 13 indexed citations
4.
Chen, Xiaowei, Guangyu Bai, Ruochuan Zang, et al.. (2023). Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer. Translational Oncology. 35. 101725–101725. 6 indexed citations
5.
Zhou, Bolun, Fenglong Bie, Ruochuan Zang, et al.. (2022). RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer. EBioMedicine. 84. 104268–104268. 30 indexed citations
6.
Zhou, Bolun, Ruochuan Zang, Moyan Zhang, et al.. (2022). Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study. EBioMedicine. 78. 103951–103951. 50 indexed citations
7.
Zhao, Liang, et al.. (2022). Consolidation Tumor Ratio Combined With Pathological Features Could Predict Status of Lymph Nodes of Early-Stage Lung Adenocarcinoma. Frontiers in Oncology. 11. 749643–749643. 5 indexed citations
8.
Zhou, Bolun, Ruochuan Zang, Moyan Zhang, et al.. (2022). Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma. International Immunopharmacology. 109. 108816–108816. 6 indexed citations
9.
Zhou, Bolun, Ruochuan Zang, Moyan Zhang, et al.. (2022). A new N descriptor for non-small cell lung cancer: the classification based on anatomic location, number and ratio of metastatic lymph nodes. Translational Lung Cancer Research. 11(8). 1540–1554. 3 indexed citations
10.
Bie, Fenglong, Nan Sun, Ruochuan Zang, et al.. (2021). Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians. Clinical Epigenetics. 13(1). 229–229. 11 indexed citations
11.
Jin, Runsen, Xinfeng Wang, Ruochuan Zang, et al.. (2020). Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma. Cancer Letters. 483. 46–58. 35 indexed citations
12.
13.
Zang, Ruochuan, Jufang Shi, Antoon Lerut, et al.. (2019). Ten-Year Trends of Clinicopathologic Features and Surgical Treatment of Lung Cancer in China. The Annals of Thoracic Surgery. 109(2). 389–395. 22 indexed citations
14.
Huang, Jianbing, Jiagen Li, Yuan Li, et al.. (2019). Interferon-inducible lncRNA IRF1-AS represses esophageal squamous cell carcinoma by promoting interferon response. Cancer Letters. 459. 86–99. 37 indexed citations
15.
Zang, Ruochuan, Xin‐Feng Wang, Runsen Jin, et al.. (2019). Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity. Journal of Translational Medicine. 17(1). 430–430. 14 indexed citations
18.
Zang, Ruochuan, Bin Qiu, Shugeng Gao, & Jie He. (2017). A Model Predicting Lymph Node Status for Patients with Clinical Stage T1aN0-2M0 Nonsmall Cell Lung Cancer. Chinese Medical Journal. 130(4). 398–403. 8 indexed citations
19.
Zhang, Moyan, Ruochuan Zang, Wendong Lei, Qi Xue, & Shugeng Gao. (2015). [Pattern of lymphatic metastasis and risk factor of esophageal carcinoma that invades less than adventitia].. PubMed. 18(9). 893–6. 2 indexed citations
20.
Zang, Ruochuan, Jie He, Yousheng Mao, et al.. (2015). [Correlation factors of lymph node metastasis in patients with clinical stage T1a non-small cell lung cancer].. PubMed. 37(4). 297–300. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026